Registration
Registration
INAUGURAL SESSION & AWARDS
INAUGURAL SESSION & AWARDS: INDIA PHARMA 2020 & INDIA MEDICAL DEVICE 2020
MEDIA INTERACTION
MEDIA INTERACTION WITH HON'BLE UNION MINISTER FOR CHEMICALS & FERTILIZERS, GoI
PHARMA AND MEDICAL DEVICES SESSION
PHARMA AND MEDICAL DEVICES SESSION WITH INTERNATIONAL DRUG REGULATORS
CONFERENCE SESSION 1
CONFERENCE SESSION 1: ROLE OF REGULATIONS IN DRIVING GROWTH OF MED-TECH
PITCHING SESSION
MED – TECH INNOVATORS PITCHING SESSION
CONFERENCE SESSION - 2: INNOVATE TO MAKE IN INDIA FOR THE WORLD
Innovation is the fuel for med tech manufacturing. Global manufacturing hubs are backed by continuous innovation and R&D inputs. Innovation represents the most valuable piece of a medical device value chain and India must tap this opportunity to FIRST Innovate, then Make and distribute in the world. We have great examples of innovations in India – space, software, automotive etc, an ecosystem is now required to replicate or create fresh channels of innovation in medical devices. Our focus on Make in India for medical devices can only see limited success in absence of local innovation and R&D. Government should encourage R&D in India to feed Make in India as technology evolves rapidly in this space. Openness to best global practices, seamless flow of innovation, recognition of international standards, policy support and incentives pave the way forward for inviting investments in R&D and therefore making India ready for the next in ‘Make in India’. The session will deliberate on the roadmap to make India a hub for medical devices innovation that leads to world class indigenous manufacturing for the domestic and overseas markets.
PHARMA & MED-TECH
JOINT SESSION FOR PHARMA & MED-TECH: AFFORDABILITY, ACCESSIBILITY AND AVAILABILITY OF QUALITY DRUGS & MEDICAL DEVICES
JOINT SESSION FOR PHARMA & MED-TECH: MERGING TRENDS IN HEALTHCARE
Technology has been the driving force over the past two decades enabling remarkable innovation and transformation in nearly every healthcare sector. These are exciting times in healthcare with vast opportunities for those who want to manage, lead and improve the quality and efficiency of healthcare delivery. While Healthcare sector could immensely benefit from this, various issues (ranging from adoption by clinicians, replacement of conventional methods to concerns on data- privacy) would need to be addressed, before these technologies are deployed to solve the myriad problems facing healthcare delivery in India. The adoption of digital services in healthcare in India has been extremely slow, but the advent of newer technology and increasing significance of healthcare data be it processes or integration with diagnostic decision making (personalized medicine) has made digital health impossible to ignore.
EXHIBITION AT THE DEDICATED PAVILIONS
India has come a long way in becoming a hub for manufacturing and supply
of generic drugs since the patent reforms in 1970 and is today touted as the
pharmacy of the world.
While India is lauded for its drive and efforts in becoming the pharmacy of
the world, the country is still at a nascent stage in terms of its activities in
commercially oriented R&D and innovation. Despite being the third largest seller
of medicines in the world, India has been able to produce only a handful of novel
commercially viable drug molecules.
This paper examines what will it take to replicate this success to novel products
and medical devices.
Drawing upon the experiences in other countries and sectors, we recommend the
following:
• Establishing top-down governance structure
• Enabling access to quality infrastructure and talent
• Creating sound and effective IP, legal and regulatory framework
• Ensuring availability of financing for research and purchase of medicine
Address
Mahatma Mandir, Gandhinagar, Gujarat
Email us
swati.aggarwal@ficci.com
Call us
+91-11-2348 7409
+91-11-2348 7355
